Tatar, B. Et Al. 2020. Role of quantitative hepatitis B surface antigen levels in predicting liver biopsy time in treatment-naive chronic hepatitis B patients. CLINICAL AND EXPERIMENTAL HEPATOLOGY , vol.6, no.1 , 55-59.

Tatar, B., Acar, A., Adar, P., & Kose, Ş., (2020). Role of quantitative hepatitis B surface antigen levels in predicting liver biopsy time in treatment-naive chronic hepatitis B patients. CLINICAL AND EXPERIMENTAL HEPATOLOGY , vol.6, no.1, 55-59.

Tatar, Bengu Et Al. "Role of quantitative hepatitis B surface antigen levels in predicting liver biopsy time in treatment-naive chronic hepatitis B patients," CLINICAL AND EXPERIMENTAL HEPATOLOGY , vol.6, no.1, 55-59, 2020

Tatar, Bengu Et Al. "Role of quantitative hepatitis B surface antigen levels in predicting liver biopsy time in treatment-naive chronic hepatitis B patients." CLINICAL AND EXPERIMENTAL HEPATOLOGY , vol.6, no.1, pp.55-59, 2020

Tatar, B. Et Al. (2020) . "Role of quantitative hepatitis B surface antigen levels in predicting liver biopsy time in treatment-naive chronic hepatitis B patients." CLINICAL AND EXPERIMENTAL HEPATOLOGY , vol.6, no.1, pp.55-59.

@article{article, author={Bengu Tatar Et Al. }, title={Role of quantitative hepatitis B surface antigen levels in predicting liver biopsy time in treatment-naive chronic hepatitis B patients}, journal={CLINICAL AND EXPERIMENTAL HEPATOLOGY}, year=2020, pages={55-59} }